rs200269437
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_001164507.2(NEB):c.24041T>C(p.Val8014Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000254 in 1,543,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V8014I) has been classified as Likely benign.
Frequency
Consequence
NM_001164507.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NEB | NM_001164507.2 | c.24041T>C | p.Val8014Ala | missense_variant | 169/182 | ENST00000427231.7 | |
NEB | NM_001164508.2 | c.24041T>C | p.Val8014Ala | missense_variant | 169/182 | ENST00000397345.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NEB | ENST00000397345.8 | c.24041T>C | p.Val8014Ala | missense_variant | 169/182 | 5 | NM_001164508.2 | P5 | |
NEB | ENST00000427231.7 | c.24041T>C | p.Val8014Ala | missense_variant | 169/182 | 5 | NM_001164507.2 | A2 |
Frequencies
GnomAD3 genomes ? AF: 0.000164 AC: 25AN: 152152Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000154 AC: 24AN: 155472Hom.: 0 AF XY: 0.000134 AC XY: 11AN XY: 82340
GnomAD4 exome AF: 0.000264 AC: 367AN: 1391726Hom.: 0 Cov.: 26 AF XY: 0.000274 AC XY: 188AN XY: 686854
GnomAD4 genome ? AF: 0.000164 AC: 25AN: 152152Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74330
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 05, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 13, 2023 | - - |
Nemaline myopathy 2 Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 28, 2024 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 30, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at